Patient-reported functional health and well-being outcomes with drug therapy: A systematic review of randomized trials using the SF-36 health survey

Medical Care

Volumn 52, Issue 5, 2014, Pages 439-445

  Frendl, Daniel M ^a   Ware, John E ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b John Ware Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; TESTOSTERONE;

ARTICLE; BACKACHE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; FIBROMYALGIA; GENERAL CONDITION IMPROVEMENT; HUMAN; INFLAMMATORY BOWEL DISEASE; MULTIPLE SCLEROSIS; NEUROPATHY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; SELF REPORT; SHORT FORM 36; SYSTEMATIC REVIEW; WELLBEING;

DOUBLE-BLIND METHOD; DRUG THERAPY; HEALTH STATUS; HEALTH SURVEYS; HUMANS; PERSONAL SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SELF REPORT; TREATMENT OUTCOME;

EID: 84898026513     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.000000000000010311     Document Type: Article

References (50)

1. Porter ME. What is value in health care? N Engl J Med. 2010;363: 2477-2481.
2. Almy TP. Comprehensive functional assessment for elderly patients. Health and Public Policy Committee, American College of Physicians. Ann Intern Med. 1988;109:70-72.
3. Garratt A, Schmidt L, Mackintosh A, et al. Quality of life measurement: bibliographic study of patient assessed health outcomes measures. BMJ. 2002;324:1417-1419.
4. Sanders C, Egger M, Donovan J, et al. Reporting on quality of life in randomised controlled trials: bibliographic study. BMJ. 1998;317: 1191-1194.
5. Croog S, Levine S, Testa M. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-1664.
6. Selby J, Beal A, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA. 2012;307:1583-1584.
7. Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167.
8. Brook R, Ware JEJ, Rogers W, et al. Does free care improve adult's health? Results from a randomized controlled trial. N Engl J Med. 1983; 309:1426-1434.
9. Deyo R, Diehl A, Rosenthal M. How many days of bed rest for acute low back pain? N Engl J Med. 1986;315:1064-1070.
10. Stewart AL, Greenfield S, Hays RD, et al. Functional status and wellbeing of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
11. Bergner M, Bobbitt R, Carter W, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
12. Ware JE. Measuring patients' views: the optimum outcome measure. BMJ. 1993;306:1429-1430.
13. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA. 1995;273:59-65.
14. Guyatt GH, King DR, Feeny DH, et al. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52:187-192.
15. Asadi-Lari M, Tamburini M, Gray D. Patients' needs, satisfaction, and health related quality of life: towards a comprehensive model. Heal Qual Life Outcomes. 2004;2:32.
16. Patrick D, Deyo R. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217-S232.
17. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003; 56:52-60.
18. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil. 2002;83(suppl 2):S10-S17.
19. Shearer D, Morshed S. Common generic measures of health related quality of life in injured patients. Injury. 2011;42:241-247.
20. Owolabi MO. Which is more valid for stroke patients: generic or strokespecific quality of life measures? Neuroepidemiology. 2010;34:8-12.
21. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010;63:1179-1194.
22. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed September 25, 2013.
23. Ware JE, Sherbourne C. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework. Med Care. 1992;30:473-483.
24. Scoggins JF, Patrick DL. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials. 2009;30:289-292.
25. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, et al. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ. 2009;338:a3006.
26. Leaf DE, Goldfarb DS. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int. 2009;75:15-24.
27. Ware JE, Kemp J, Buchner D. The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res. 1998;7:235-244.
28. Rahimi K, Malhotra A, Banning AP, et al. Outcome selection and role of patinet reported outcomes in contemporary cardiovascular trials: systematic review. BMJ. 2010;341:C5707.
29. Jull A, Parag V, Walker N, et al. Responsiveness of generic and diseasespecific health-related quality of life instruments to venous ulcer healing. Wound Repair Regen. 2010;18:26-30.
30. Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3:57-71.
31. Norman G, Sloan J, Wyrwich K. Interpretation of changes in healthrelated quality of life the remarkable universality of half a standard deviation. Med Care. 2003;41:582-592.
32. Guyatt GH, Naylor CD, Juniper E, et al. Users' guides to the medical literature, XII. How to use articles about health-related quality of life. Evidence-based Medicine Working Group. JAMA. 1997;277: 1232-1237.
33. Guyatt GH, Osoba D, Wu AW, et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77: 371-383.
34. Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2008;14:234-254.
35. Ware JE, Kosinski M, Bjorner J, et al. User's Manual for the SF 36v2s Health Survey. 2nd ed. Lincoln, RI: QualityMetric Incorporated; 2007;11.
36. Ware JE, Kosinski M, Keller SA. 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
37. Jadad A, Moore R, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
38. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(suppl):AS264-AS279.
39. Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448-457.
40. Barnes PJ. New treatments for COPD. Nat Rev Drug Discov. 2002;1: 437-446.
41. Goldenberg D. Management of fibromyalgia syndrome. JAMA. 2004; 292:2388-2395.
42. Chan AW, Hro'bjartsson A, Haahr MT, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457-2465.
43. Chan A-W, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ. 2005;330:753.
44. Dwan K, Altman DG, Arnaiz Ja, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3:e3081.
45. Calvert M, Blazeby J, Altman DG, et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309:814-822.
46. Manary MP, Boulding W, Staelin RGS. The patient experience and health outcomes. N Engl J Med. 2013;368:201-203.
47. Ware JE, Gandek B, Sinclair SJ, et al. Item response theory and computerized adaptive testing: Implications for outcomes measurement in rehabilitation. Rehabil Psychol. 2005;50:71-78.
48. Rose M, Bjorner JB, Becker J, et al. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient- Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2008;61:17-33.
49. Ware JE. Conceptualization and measurement of health-related quality of life: comments on an evolving field. Arch Phys Med Rehabil. 2003; 84:43-51.
50. Wahl I, Lowe B, Bjorner JB, et al. Standardization of depression measurement: a common metric was developed for 11 self-report depression measures. J Clin Epidemiol. 2014;67:73-86.